GLP-1 RA-exposed pregnancies compared to matched control groups When estimating the Average Treatment Effect on the Treated (ATT), we did not observe any differences in birth weight, placental weight or the frequency of SGA or LGA, GDM or pre-eclampsia between GLP-1 RA exposure and any of the six control groups (Fig
Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, et al
Consequently, light-skinned individuals do not lack the hardware to produce pigment, as they have the same number of melanocytes
Additionally, those taking other medications that relax the lower esophageal sphinctersuch as anticholinergics or calcium channel blockersmay experience compounded reflux when adding Zepbound
This reduces the risk of dangerous low blood sugar episodes